Orexigen Therapeutics, Inc. ‘s ( OREX ) shares were down 14.68% after the company announced that the FDA has delayed …read more
Orexigen Slumps as Obesity Drug Approval Delayed – Analyst Blog
- by Bob Mitchell
Orexigen Therapeutics, Inc. ‘s ( OREX ) shares were down 14.68% after the company announced that the FDA has delayed …read more